Prognostic Implications of Manual versus Digital PD-L1 Expression in pT3 and pT4 Colon Carcinoma - Top-Institutions - MDSpire

Prognostic Implications of Manual versus Digital PD-L1 Expression in pT3 and pT4 Colon Carcinoma

  • By

  • Dea Natalie Munch Jepsen

  • Marianne Bøgevang Jensen

  • Astrid Louise Bjørn Bennedsen

  • Trine Lønbo Grantzau

  • Thomas Thiilmark Eriksen

  • Jens Ole Eriksen

  • Michael Bzorek

  • Ismail Gögenur

  • Anne-Marie Kanstrup Fiehn

  • November 21, 2025

  • 0 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer
    • Immunotherapy
    • Pathology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Molecular Pathology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Gastrointestinal Cancer
    • Immunotherapy

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Pathology
    • Immunotherapy

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Digital Pathology

Original Source(s)

Prognostic Implications of Manual versus Digital PD-L1 Expression in pT3 and pT4 Colon Carcinoma

  • by Dea Natalie Munch Jepsen, Marianne Bøgevang Jensen, Astrid Louise Bjørn Bennedsen, Trine Lønbo Grantzau, Thomas Thiilmark Eriksen, Jens Ole Eriksen, Michael Bzorek, Ismail Gögenur, Anne-Marie Kanstrup Fiehn

  • November 21, 2025

Related Content

Biomarkers Expand Precision in CRC

Emerging biomarkers guide colorectal cancer diagnosis, stratification, and treatment selection

Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

Immunoscore Refines CRC Prognosis, Therapy

Despite a strong evidence base, the assay has not been widely implemented in routine clinical practice.